Beyond Air (XAIR) CFO Daniel Moorhead Buys Stock and Warrants

What Happened

• Daniel J. Moorhead, Chief Financial Officer of Beyond Air, purchased 4,340 shares of common stock on July 29, 2026, at $5.76 per share for a reported cash outlay of $24,998. The filing also shows two related derivative acquisitions (Series A and Series B warrants) tied to the same transaction; the combined purchase price for each share plus its paired warrants was $5.76.
• This was a purchase (reported with code P), which retail investors often view as a more informative action than routine sales because it represents an insider adding to holdings.

Key Details

• Transaction date: 2026-07-29; Form 4 filed: 2026-07-31 (filed within required reporting window).
• Shares purchased: 4,340 common shares at $5.76 each; total reported cash value $24,998.
• Derivative securities: two warrant series (Series A and Series B) were acquired alongside the shares. The warrants are exercisable immediately upon issuance (footnote F1).
• Warrant terms (from footnotes): one warrant series expires on the earlier of (i) the first anniversary of issuance or (ii) 45 days after FDA approval of the Company’s pending premarket approval supplement for LungFit PH II (F2); the other series expires five years after issuance (F4). Footnote F3 notes each Series A and Series B warrant was purchased together with one share for a combined $5.76.
• Shares owned after the transaction: not specified in the filing.
• Filing timeliness: Reported period 7/29, filed 7/31 — appears timely under Form 4 rules.

Context

• The filing records a purchase plus accompanying warrants rather than an option exercise or sale. The warrants were issued with the share purchase (not a cashless exercise), and are immediately exercisable per the filing.
• As always, purchases by insiders are factual signals of personal investment but do not guarantee future company performance.